Save the date
Neuroinflammation & Epilepsy
From Mechanisms to Precision Immunotherapy
International Training School and Translational Workshop
Fall 2027 · 2.5 days
Paris Brain Institute (ICM), Paris
Registration opens soon
At the heart of the programme
NORSE & Rasmussen encephalitis
Two rare, immune‑mediated epilepsies — one acute, one chronic — that together show how neuroinflammation drives seizures, and how it can be treated.
NORSE
New‑onset refractory status epilepticus
A rare, life‑threatening presentation in which refractory status epilepticus occurs in a patient without prior epilepsy and without an identifiable acute structural, toxic or metabolic cause. FIRES is its subtype preceded by a febrile infection.
- Sudden onset, often in previously healthy people
- Affects both children and adults
- Inflammation‑driven: immunotherapy increasingly used
Rasmussen
Encephalitis
A rare, chronic inflammatory disease of the brain, usually beginning in childhood and affecting one cerebral hemisphere. It causes drug‑resistant focal seizures, progressive neurological deficits and hemispheric atrophy.
- Progressive course over months to years
- Mostly children, sometimes adults
- T‑cell–mediated inflammation: immunotherapy and surgery
Key information
When & where
When
Fall 2027
Exact dates to be announced
Format
2.5 days
International training school & translational workshop
Where
Paris Brain Institute (ICM)
Pitié‑Salpêtrière Hospital, 47 boulevard de l'Hôpital, 75013 Paris, France
A word from the organizers
Welcome
Pr. Vincent Navarro
Neurologist — Team Leader
Dr. Aurélie Hanin
Research Coordinator & Biologist
Dear Colleagues,
It is our great pleasure to announce Neuroinflammation & Epilepsy: From Mechanisms to Precision Immunotherapy, an international training school and translational workshop that will take place over two and a half days in fall 2027 at the Paris Brain Institute.
Organised by the NORSE‑ICM team, it will focus on immune‑mediated epilepsies, with a particular emphasis on New Onset Refractory Status Epilepticus (NORSE) and Rasmussen encephalitis. From the mechanisms of neuroinflammation to precision immunotherapy, the programme will bring together clinicians, researchers and trainees from across Europe and beyond, to share the latest advances and strengthen collaborations between our centres.
The scientific programme, registration and abstract submission will be announced in the coming months. We look forward to welcoming you to Paris.
With warm regards,
Pr. Vincent Navarro & Dr. Aurélie Hanin
on behalf of the NORSE‑ICM team
Stay tuned
Coming soon
Scientific programme
Sessions, speakers and round tables will be published here.
Registration
Fees, deadlines and online registration will be published here. Register your interest now to be notified.
Abstract submission
Call for abstracts and deadlines to be announced.
Venue
Paris Brain Institute
The meeting will be held at the Paris Brain Institute (ICM), located on the campus of the Pitié‑Salpêtrière Hospital in the heart of Paris.
Pitié‑Salpêtrière Hospital, 47 boulevard de l'Hôpital, 75013 Paris, France
Open in Google Maps →Register your interest
Registration opens soon. Register your interest and we will notify you as soon as the programme and online registration are available.